Formulation considerations for the development of medications with abuse potential
Open Access
- 30 June 2006
- journal article
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 83, S15-S22
- https://doi.org/10.1016/j.drugalcdep.2005.10.018
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Assessing abuse liability in clinical trialsDrug and Alcohol Dependence, 2003
- Principles of initial experimental drug abuse liability assessment in humansDrug and Alcohol Dependence, 2003
- Postmarketing surveillance for drug abuseDrug and Alcohol Dependence, 2003
- Effect of intravenous injection speed on responses to cocaine and hydromorphone in humans.Psychopharmacology, 2001
- Inhibition of Cytochrome P450 2D6 Modifies Codeine Abuse LiabilityJournal of Clinical Psychopharmacology, 2000
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settingsAdvanced Drug Delivery Reviews, 1997
- Preference for high- versus low-potency marijuanaPharmacology Biochemistry and Behavior, 1994
- Subjective and behavioral effects of diazepam depend on its rate of onsetPsychopharmacology, 1993
- The effect of particle size distribution on dissolution rate and oral absorptionInternational Journal of Pharmaceutics, 1989
- FIXED‐INTERVAL SCHEDULE OF COCAINE REINFORCEMENT: EFFECT OF DOSE AND INFUSION DURATION1Journal of the Experimental Analysis of Behavior, 1973